Langsung ke konten
Global sound
The Energy Code

The Energy Code

Intranasal Peptides Explained: Brain Repair, Mitochondria, Stress & Recovery

· 53 mnt · Episode 387

Catatan episode

What if the future of peptide therapy isn't just about which peptide you use — but where you deliver it?
In this episode of The Energy Code, Dr. Mike Belkowski explores one of the most intriguing frontiers in peptide research: intranasal delivery and its potential to create a more brain-oriented route for peptides that influence neurological function, tissue repair, stress regulation, and mitochondrial biology.
The episode begins with the science of nose-to-brain delivery, including the olfactory and trigeminal pathways, systemic absorption through the nasal mucosa, and the possibility of partially circumventing one of neuroscience's biggest obstacles: the blood-brain barrier. But Mike also explains why “intranasal” alone tells us very little about pharmacology — formulation, stability, deposition, device design, concentration, and nasal anatomy can all dramatically affect what actually happens.
Then he breaks down four intriguing formulations: BPC-157, oxytocin, MOTS-c, and MOTS-c + SS-31.
BPC-157 is explored as the repair and regeneration hypothesis, with preclinical research involving traumatic brain injury, ischemia, spinal cord injury, vascular signaling, inflammation, and tissue repair. Oxytocin represents the neuromodulation hypothesis and has by far the strongest direct human intranasal evidence of the four.
MOTS-c takes the conversation directly into mitochondrial medicine. As a mitochondrial-derived signaling peptide, it may help cells recognize and adapt to metabolic stress — and emerging animal research raises fascinating questions about its potential neurological applications. Finally, Mike explores what may be the most intriguing mechanistic pairing: MOTS-c + SS-31, combining cellular metabolic adaptation with direct mitochondrial membrane and cardiolipin support.
The key question isn't simply “What does this peptide do?”
It's: Can we get the peptide to the place where we need it for it to be most effective?
(Educational content only, not medical advice.)
-
Key Quotes From Dr. Mike:
“The biggest question in peptide medicine... is not simply, what does this peptide do? Rather, can we get this peptide to the place where we need it for it to be most effective?”
“The fact that BPC-157 has interesting TBI data does not mean intranasal BPC-157 has been demonstrated to treat concussion.”
“Oxytocin may amplify or reshape social processing rather than simply producing a universally positive emotional state.”
“There's a possible connection between oxytocin and the body's ability to shift from a defensive state toward a state of social safety and physiological recovery.”
“MOTS-c biology may be therapeutically interesting in the brain, and intranasal delivery may be one potential strategy for overcoming the blood-brain barrier problem.”
“SS-31 essentially targets that energetic crisis at the mitochondrial membrane itself (via cardiolipin)."
“SS-31 helps stabilize the mitochondrial hardware. MOTS-c helps regulate the cellular software.”
-
Key…

Situs: theenergycode.podbean.com

Live, satu jam terakhir: 13.499 lagu di 7.040 stasiun di 146 negara

Jelajahi dunia lewat radio

Cara lain untuk menjelajah (7)

Dengar sesuatu yang bagus? Simpan, atau langsung buka di Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio Kolhabi 104.1 MhzLanjut mendengarkan